HDAC9 and nervous system disorder: Compounds were selected based on known neuroactivity and represent diverse mechanisms of action implicated in many neurological disorders, including calcium channel blockers, glutamate receptor antagonists, acetylcholine receptor agonists, and HDAC inhibitors (Figure 2b, Supplemental Table 1).